2026. JAK2V617F mutation detection in patients with clinical suspicion of myeloproliferative neoplasm without leukemic expression. Preliminary study. Anales of the Faculty of Medical Sciences. 47, 2 (Oct. 2026), 41–49. DOI:https://doi.org/10.18004/.